DFTX
#1334
Definium Therapeutics, Inc. - Common Shares
45.9 8 USD
+0.05%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+5.34%
Variación mensual
+94.42%
Variación en los últimos 6 meses
+196.84%
Cambio anual
+204.30%
Cierres anteriores
43.6 5
Open
45.9 8
Mínimo
45.9 8
High
45.9 8
Volumen
127
Financials
- Market Capitalization 5.01 B
- Employee 106
- Founded 2010
- CEO Robert Barrow
- Website www.definiumtx.com
- Headquarter British Columbia, Canada
- FIGI BBG00F13HYQ7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-7.81
Relación precio/flujo de caja
-11.11 K
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1286 |  CELC Celcuity Inc. - Common Stock | 111.05 USD | +6.99% | -2.59% | +25.42% | +700.65% | 5.42 B USD | ||
| 1299 |  TVTX Travere Therapeutics, Inc. - Common Stock | 57.06 USD | +1.37% | -0.77% | +5.90% | +98.33% | 5.31 B USD | ||
| 1361 |  CRSP CRISPR Therapeutics AG - Common Shares | 50.46 USD | -0.34% | -13.80% | -4.25% | -5.58% | 4.87 B USD | ||
| 1377 |  LEGN Legend Biotech Corporation - American Depositary Shares | 25.67 USD | -0.31% | -6.69% | -26.68% | -19.73% | 4.75 B USD |